Joint effect of the SMN2 and SERF1A genes on childhood-onset types of spinal muscular atrophy in Serbian patients-Reference-Cited by-同舟云学术

Joint effect of the SMN2 and SERF1A genes on childhood-onset types of spinal muscular atrophy in Serbian patients

Published:2015-08-27 Issue:11 Volume:60 Page:723-728
ISSN:1434-5161
Container-title:Journal of Human Genetics
language:en
Short-container-title:J Hum Genet

Author:

Brkušanin Miloš,Kosać Ana,Jovanović Vladimir,Pešović Jovan,Brajušković Goran,Dimitrijević Nikola,Todorović Slobodanka,Romac Stanka,Milić Rašić Vedrana,Savić-Pavićević Dušanka

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://www.nature.com/articles/jhg2015104.pdf

Reference35 articles.

1. Pearn, J. Incidence, prevalence and gene frequency studies of chronic childhood spinal muscular atrophy. J. Med. Genet. 15, 409–413 (1978).

2. Cusin, V., Clermont, O., Gerard, B., Chantereau, D. & Elion, J. Prevalence of SMN1 deletion and duplication in carrier and normal populations: implication for genetic counselling. J. Med. Genet. 40, e39 (2003).

3. Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155–165 (1995).

4. Wirth, B., Herz, M., Wetter, A., Moskau, S., Hahnen, E., Rudnik-Schöneborn, S. et al. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am. J. Hum. Genet. 64, 1340–1356 (1999).

5. Munsat, T. L. & Davies, K. E. International SMA consortium meeting. (26-28 June 1992, Bonn, Germany). Neuromuscul. Disord. 2, 423–428 (1992).

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Our Journey from Individual Efforts to Nationwide Support: Implementing Newborn Screening for Spinal Muscular Atrophy in Serbia;International Journal of Neonatal Screening;2024-08-15

2. Phosphorylated neurofilament heavy chain in cerebrospinal fluid and plasma as a Nusinersen treatment response marker in childhood-onset SMA individuals from Serbia;Frontiers in Neurology;2024-05-02

3. The impact of three SMN2 gene copies on clinical characteristics and effect of disease-modifying treatment in patients with spinal muscular atrophy: a systematic literature review;Frontiers in Neurology;2024-02-29

4. Elevated levels of FMRP-target MAP1B impair human and mouse neuronal development and mouse social behaviors via autophagy pathway;Nature Communications;2023-06-26

5. Investigation on the Effects of Modifying Genes on the Spinal Muscular Atrophy Phenotype;Global Medical Genetics;2022-09